Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis

• Published in: Journal of orthopaedic research Vol. 17; no. 6; pp. 858 - 869
• Main Authors: Kang, Yong, Eger, Wolfgang, Koepp, Holger, Williams, James M., Kuettner, Klaus E., Homandberg, Gene A.
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.1999
• Subjects: Adolescent; Aged; Biodegradation; Biosynthesis; Cartilage - drug effects; Cartilage - metabolism; Enzymes; Epitopes; Female; Fibronectins - antagonists & inhibitors; Fibronectins - toxicity; Humans; Hyaluronic Acid - pharmacology; Joints (anatomy); Knee Joint - drug effects; Male; Matrix Metalloproteinase 3 - metabolism; Middle Aged; Molecular weight; Organ Culture Techniques; Osteoarthritis - drug therapy; Peptide Fragments - antagonists & inhibitors; Polysaccharides; Proteoglycans - biosynthesis; Tissue culture
• ISSN: 0736-0266; 1554-527X
• DOI: 10.1002/jor.1100170611

Hyaluronic acid, recently renamed hyaluronan, has been used as a therapeutic intervention in the treatment of osteoarthritis. We have reported that high‐molecular‐weight (800 kDa) hyaluronan is effective in blocking the catabolic action of fibronectin fragments in explant cultures of bovine cartilage and in an experimental in vivo model of damage to the rabbit knee joint. The fibronectin fragments induce catabolic cytokines in human cartilage, which, in turn, suppress proteoglycan synthesis and induce matrix metalloproteinases to decrease the proteoglycan content. Since the clinical target of high‐molecular‐weight hyaluronan is human cartilage, which may differ in certain ways from bovine cartilage, we tested the effect on human knee cartilage. We found that 1 mg/ml hyaluronan completely blocked fibronectin fragment‐mediated decreases in proteoglycan content in five of five specimens of cartilage from the human knee. This was associated with binding of exogenous hyaluronan to the superficial surface, suppressed penetration of the fibronectin fragment into the cartilage, decreased expression for the first week in culture of one of the matrix metalloproteinases involved in cartilage degradation, matrix metalloproteinase‐3, and proteoglycan synthesis rates that increased to supernormal levels. However, the appearance of the NITEGE and VDIPEN neoepitopes, indices of cartilage degradation, was not blocked but was delayed by 1 week. The addition of hyaluronan to cartilage previously damaged by the fibronectin fragments or to osteoarthritic cartilage fully restored the proteoglycan content to control levels. We conclude that hyaluronan blocked damage at least partly by blocking penetration of the fibronectin fragments and slowing matrix metalloproteinase expression. However, the major effect on blocking damage and promoting repair may be through enhanced proteoglycan synthesis, a mechanism that requires further study. Nonetheless, these data clearly demonstrate that hyaluronan completely protected human cartilage in explant culture and facilitated a full restoration of proteoglycan in damaged cartilage.